Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day ...Middle East

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the Guggenheim 4th Annual...

Hence then, the article about seelos therapeutics to participate in the guggenheim 4th annual immunology and neurology day was published today ( Monday 07/11/2022 - 09:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day )

Also on site :

• Hundreds of flights delayed at O'Hare after pipe burst at air traffic control tower
• Two dead in floods & torrential rains sweeping through Tunisia
• ‘High School Musical’ Turns 20 Today! See Where the Cast Is Now